AegirBio AB (publ)

    AegirBio AB (publ)

    SSTO:AEGIR
    0.43
    SEK
    0.00
    (0.00%)
    AegirBio AB (publ)
    STO:AEGIR
    (Nasdaq Stockholm)

    Recent

    price

    0.43

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2019
    2020
    2021
    2022
    2023
    2024
    2025
    TTM
    SEK
    - -
    - -
    117.21
    11.78
    0.3
    661.15
    1.32
    202.02
    Revenue per Share
    - -
    -145.2
    -814.81
    -2,506.36
    -195.94
    12.76
    -0.33
    -24.17
    Basic EPS, GAAP
    - -
    -103.92
    -955.05
    -338.91
    -156.72
    -153.46
    -0.32
    -28.88
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    15.45
    396.83
    2,602.08
    248.19
    0.72
    733.01
    0.41
    -25.11
    Book Value per Share
    0.91
    81.94
    260.52
    -29.5
    -154.59
    -218.82
    -0.05
    -33.91
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    155
    1
    Basic Weighted Avg Shares
    - -
    - -
    13
    2
    - -
    204
    204
    162
    Sales/Revenue/Turnover
    - -
    - -
    -613.73
    -5,263.31
    -61,041.3
    19.7
    -15.18
    -0.92
    Operating Margin (%)
    - -
    - -
    8
    12
    17
    24
    25
    8
    Depreciation Expense
    - -
    -10
    -92
    -363
    -60
    4
    -51
    -19
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    36.99
    - -
    12.46
    Effective Tax Rate (%)
    - -
    - -
    -695.14
    -21,267.88
    -64,886.96
    1.93
    -24.91
    -11.97
    Profit Margin (%)
    - -
    8
    50
    2
    7
    -104
    -30
    -25
    Working Capital
    - -
    1
    - -
    - -
    32
    6
    4
    32
    LT Debt
    1
    39
    370
    40
    - -
    345
    418
    -47
    Total Equity
    - -
    - -
    - -
    - -
    - -
    10.56
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    -5.13
    - -
    -187.15
    Return on Capital (%)
    - -
    -52.03
    -45.11
    -176.88
    -298.52
    2.28
    -13.35
    -24.12
    Return on Common Equity (%)

    Capital Structure

    SEK

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    99
    - -
    1
    LT Borrowings
    - -
    - -
    32
    LT Finance Leases
    6
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    - -
    - -
    2
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    SEK

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    87
    - -
    2
    Cash, Cash Equivalents & STI
    27
    - -
    - -
    Accounts Receivable, Net
    49
    - -
    2
    Inventories
    9
    - -
    - -
    Total Current Liabilities
    191
    - -
    27
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    99
    - -
    1
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    SEK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    41,131.16%
    21.43%
    Free Cash Flow
    - -
    261.72%
    5.41%
    Net Income, GAAP
    - -
    -100.04%
    -1,395.37%
    Sales/Revenue/Turnover
    - -
    - -
    0.31%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    55
    204
    2025
    41
    66
    - -
    57
    204
    2026
    47
    62
    - -
    - -
    - -

    Quarterly Earnings Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -20.9
    -34.49
    -49.79
    -35.63
    12.76
    2025
    -3.98
    6.37
    - -
    -0.13
    -0.33
    2026
    - -
    -0.01
    - -
    - -
    - -

    Quarterly Dividends Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business